Lobbying Information
Subject Matters
- Economic Development
- Health
- Industry
- Intellectual Property
- International Trade
- Research and Development
- Science and Technology
- Taxation and Finance
Subject Matter Details
Policies or Program
- Canada’s Innovation and Skills Plan, led by Innovation, Science and Economic Development Canada, specifically aspects related to the pharmaceutical and life sciences sector, including intellectual property protection and attraction of investments in research and development.
- Engagement with federal officials regarding Innovation, Science and Economic Development Canada’s plans for the creation of new research and biomanufacturing capacity for Canada.
- Federal programs and budgetary initiatives related to the Federal-Provincial-Territorial funding arrangements regarding pharmaceuticals including addressing any health technology assessment-related or other policy discussions that might involve Health Canada and its ongoing relationship with the Canadian Agency for Drugs and Technologies in Health (CADTH) and/or other pan-Canadian health organizations.
- Implementation of the Biomanufacturing and Life Sciences Strategy by ISED and Health Canada.
- Innovation, Science and Economic Development Canada and Innovation Agenda, Science and Technology Strategy, or other Government policy or program initiatives to support research and development activities in Canada.
Regulation
- Guidelines, policies and programs related to regulatory and reporting functions of the Patented Medicine Prices Review Board.
Communication Techniques
-
Written communication
-
Oral communication
The lobbyist has arranged or expects to arrange one or more meetings on behalf of the client between a public office holder and any other person in the course of this undertaking.
Government Institutions
-
Health Canada (HC)
-
Innovation, Science and Economic Development Canada (ISED)
-
Patented Medicine Prices Review Board (PMPRB)
-
Prime Minister's Office (PMO)
-
Privy Council Office (PCO)
Client Details
Government funding
No government funding was received during the last completed financial year.
Client Contact Information
Address:
1004 Middlegate Rd
Mississauga, ON L4Y 1M4
Canada
Telephone number:
905-277-7111
Client representative
Isabelle Gagnon, Senior Manager, Federal Government Affairs
Parent Company Information
AstraZeneca Canada is not a subsidiary of any other parent companies.
Coalition Members Information
AstraZeneca Canada is not a coalition.
Individual, organization or corporation with a Direct Interest Beneficiary Information
The activities of AstraZeneca Canada are not controlled or directed by another individual, organization or corporation with a direct interest in the outcome of this undertaking.
Subsidiary Beneficiary Information
AstraZeneca Canada does not have any subsidiaries that could have a direct interest in the outcome of the undertaking
Lobbyist Details
WILLIAM DEMPSTER
|
Public offices held
Business address:
150 Metcalfe Street
Suite 604
OTTAWA, ON K2P 1P1
Canada
Telephone number:
613-614-0283
Fax number:
613-249-3645
Consultant Firm and Address
Firm:
3Sixty Public Affairs Inc. / 3Sixty Public Affairs Inc.
Address:
150 Metcalfe Street
Suite 604
Ottawa, ON K2P 1P1
Canada
Telephone number:
613-800-8340
Fax number:
613-800-8343
